| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.7M | -11.4% |
| Cost of Revenue | $11.6M | -9.1% |
| Gross Profit | $6.1M | -15.6% |
| R&D Expense | $10.2M | -13.5% |
| SG&A Expense | $8.9M | -14.7% |
| Operating Income | -$22.8M | -3.7% |
| Pre-tax Income | -$22.1M | -23.1% |
| Income Tax | -$150K | -149.2% |
| Net Income | -$21.9M | -20.2% |
| EPS (Basic) | -$1.24 | -7.8% |
| EPS (Diluted) | -$1.24 | -7.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | -59.4% |
| Accounts Receivable | $3.9M | -14.5% |
| Current Assets | $16.8M | -51.4% |
| Total Assets | $19.3M | -54.1% |
| Current Liabilities | $4.3M | -30.6% |
| Total Liabilities | $5.7M | -39.4% |
| Stockholders' Equity | $13.6M | -58.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.6M | +19.6% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$1.8M | -2.4% |
| Financing Cash Flow | -$209K | -128.2% |
| Free Cash Flow | -$14.6M | +19.7% |